Age-dependent regulation of antioxidant genes by p38α MAPK in the liver

被引:8
|
作者
Perez, Salvador [1 ]
Rius-Perez, Sergio [1 ]
Tormos, Ana M. [1 ]
Finamor, Isabela [1 ]
Nebreda, Angel R. [2 ,3 ]
Talens-Visconti, Raquel [4 ]
Sastre, Juan [1 ]
机构
[1] Univ Valencia, Sch Pharm, Dept Physiol, Avda Vicente Andres Estelles S-N, E-46100 Burjassot, Valencia, Spain
[2] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain
[3] ICREA, Pg Lluis Co 23, Barcelona 08010, Spain
[4] Univ Valencia, Dept Pharm & Pharmaceut Technol & Parasitol, Sch Pharm, E-46100 Burjassot, Spain
来源
REDOX BIOLOGY | 2018年 / 16卷
关键词
Nuclear factor kappa B; Glutathione; Glutamate cysteine ligase; Superoxide dismutase 1; Superoxide dismutase 2; And catalase; NF-KAPPA-B; ONCOGENE-INDUCED SENESCENCE; RIBOSOMAL S6 KINASE-1; P38; MAPK; OXIDATIVE STRESS; CELL-PROLIFERATION; SIGNALING PATHWAY; ENDOTHELIAL-CELLS; REDOX REGULATION; SKELETAL-MUSCLE;
D O I
10.1016/j.redox.2018.02.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p38 alpha is a redox sensitive MAPK activated by pro-inflammatory cytokines and environmental, genotoxic and endoplasmic reticulum stresses. The aim of this work was to assess whether p38 alpha controls the antioxidant defense in the liver, and if so, to elucidate the mechanism(s) involved and the age-related changes. For this purpose, we used liver-specific p38 alpha-deficient mice at two different ages: young-mice (4 months-old) and old-mice (24 months-old). The liver of young p38 alpha knock-out mice exhibited a decrease in GSH levels and an increase in GSSG/GSH ratio and malondialdehyde levels. However, old mice deficient in p38 alpha had higher hepatic GSH levels and lower GSSG/GSH ratio than young p38 alpha knock-out mice. Liver-specific p38 alpha deficiency triggered a dramatic down-regulation of the mRNAs of the key antioxidant enzymes glutamate cysteine ligase, superoxide dismutase 1, superoxide dismutase 2, and catalase in young mice, which seems mediated by the lack of p65 recruitment to their promoters. Nrf-2 nuclear levels did not change significantly in the liver of young mice upon p38 alpha deficiency, but nuclear levels of phospho-p65 and PGC-1 alpha decreased in these mice. p38 alpha-dependent activation of NF-kappa B seems to occur through classical I kappa B Kinase and via ribosomal S6 kinasel and AKT in young mice. However, unexpectedly the long-term deficiency in p38 alpha triggers a compensatory up-regulation of antioxidant enzymes via NF-kappa B activation and recruitment of p65 to their promoters. In conclusion, p38 alpha MAPK maintains the expression of antioxidant genes in liver of young animals via NF-kappa B under basal conditions, whereas its long-term deficiency triggers compensatory up-regulation of antioxidant enzymes through NF-kappa B.
引用
收藏
页码:276 / 284
页数:9
相关论文
共 50 条
  • [41] p38 MAPK Signaling in Osteoblast Differentiation
    Rodriguez-Carballo, Eddie
    Gamez, Beatriz
    Ventura, Francesc
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2016, 4
  • [42] Activin can activate p38 MAPK
    Elena Neumann
    [J]. Arthritis Research & Therapy, 3 (1)
  • [43] P38 MAPK and Radiotherapy: Foes or Friends?
    Garcia-Flores, Natalia
    Jimenez-Suarez, Jaime
    Garnes-Garcia, Cristina
    Fernandez-Aroca, Diego M.
    Sabater, Sebastia
    Andres, Ignacio
    Fernandez-Aramburo, Antonio
    Ruiz-Hidalgo, Maria Jose
    Belandia, Borja
    Sanchez-Prieto, Ricardo
    Cimas, Francisco J.
    [J]. CANCERS, 2023, 15 (03)
  • [44] p38 MAPK in cardioprotection - are we there yet?
    Martin, E. D.
    Bassi, R.
    Marber, M. S.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (08) : 2101 - 2113
  • [45] NSAIDs inhibit p38 MAPK activation
    Cheryl Smythe
    [J]. Arthritis Research & Therapy, 4 (1)
  • [46] Activin can activate p38 MAPK
    Neumann E.
    [J]. Breast Cancer Research, 3 (1)
  • [47] Increased activation of p38 MAPK in COPD
    Renda, T.
    Baraldo, S.
    Pelaia, G.
    Bazzan, E.
    Turato, G.
    Papi, A.
    Maestrelli, P.
    Maselli, R.
    Vatrella, A.
    Fabbri, L. M.
    Zuin, R.
    Marsico, S. A.
    Saetta, M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (01) : 62 - 69
  • [48] P38α MAPK is required for contact inhibition
    Faust, D
    Dolado, I
    Cuadrado, A
    Oesch, F
    Weiss, C
    Nebreda, AR
    Dietrich, C
    [J]. ONCOGENE, 2005, 24 (53) : 7941 - 7945
  • [49] p38α MAPK is required for contact inhibition
    Dagmar Faust
    Ignacio Dolado
    Ana Cuadrado
    Franz Oesch
    Carsten Weiss
    Angel R Nebreda
    Cornelia Dietrich
    [J]. Oncogene, 2005, 24 : 7941 - 7945
  • [50] Pyridazine based inhibitors of p38 MAPK
    McIntyre, CJ
    Ponticello, GS
    Liverton, NJ
    O'Keefe, SJ
    O'Neill, EA
    Pang, M
    Schwartz, CD
    Claremon, DA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (04) : 689 - 692